MedTrace Logo

Comparative Safety and Efficacy Study of New Bifonazol Spray vs Terbinafine Solution vs Placebo

NCT01013909 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2015-01-27

No results posted yet for this study

Summary

The study shall prove whether 6 consecutive doses of Bifonazole spray show comparable efficacy to a Terbinafine solution applied once.

Conditions

  • Tinea Pedis

Interventions

DRUG

Bifonazole spray once daily

Application of one dose daily by means of an metered dose

DRUG

Bifonazole spray twice daily

Application of two dose daily by means of an metered dose

DRUG

Placebo

Application of one dose daily by means of an metered dose

DRUG

Placebo

Application of one dose daily by means of an metered dose

DRUG

Lamisil Once

One application of Lamisil Once

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01013909 on ClinicalTrials.gov